EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic

Hazheer M Hamad, Hanan T Subhi

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.17885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Hazheer M Hamad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of science and health, Koya University, Koya KOY45, Kurdistan Region - F.R. Iraq. Hauptthemen laut MEDLINE: Acinetobacter baumannii, COVID-19, Acinetobacter Infections, Drug Resistance, Multiple, Bacterial. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acinetobacter baumannii is endemic in hospital environments, and since the coronavirus disease 2019 (COVID-19) pandemic, multidrug-resistant A. baumannii has become more potent. This potential evolution is driven by the undetectable numbers of gene resistances it has acquired. We evaluated the antibiotic-resistance genes in isolates from patients in Erbil hospitals. Methodology: This is the first study to demonstrate the antimicrobial resistance epidemic in Erbil, Iraq. A total of 570 patients, including 100 COVID-19 patients were tested. Isolate identification, characterization, antibiotics susceptibility test, polymerase chain reaction (PCR) amplification of the antibiotic resistance genes in both bacterial chromosome and plasmid, 16S-23S rRNA gene intergenic spacer (ITS) sequencing using the Sanger DNA sequencing, and phylogenetic analysis were used in this study.

Results

Only 13% of A. baumannii isolates were from COVID-19 patients. All isolates were multi-drug resistant due because of 24 resistance genes located in both the bacterial chromosome or the plasmid. blaTEM gene was detected in the isolates; however, aadB was not detected in the isolated bacteria. New carbapenemase genes were identified by Sanger sequencing and resistance genes were acquired by plasmids.

Conclusions

The study identified metabolic differences in the isolates; although all the strains used the coumarate pathway to survive. Several resistance genes were present in the isolates’ plasmids and chromosome. There were no strong biofilm producers. The role of the plasmid in A. baumannii resistance development was described based on the results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiCOVID-19Acinetobacter InfectionsDrug Resistance, Multiple, BacterialHumansIraqAnti-Bacterial AgentsSARS-CoV-2Disease OutbreaksMicrobial Sensitivity TestsPhylogenyPlasmidsHospitalsBacterial ProteinsMaleFemale

Stichwörter der Autor:innen

A. baumanniiPlasmidblaTEMcarbapenemase genesresistance genes

Substanzen

Anti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Biology, Faculty of science and health, Koya University, Koya KOY45, Kurdistan Region - F.R. Iraq.

Zitieren

APA

Hamad, H. M., & Subhi, H. T. (2024). Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17885

Vancouver

Hamad HM, Subhi HT. Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.17885

BibTeX
@article{Hamad2024,
  author = {Hamad, Hazheer M and Subhi, Hanan T},
  title = {Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.17885}
}
Kostenlos starten →